SCHOLARS@TAMU

Kapoor, S., Gustafson, T., Zhang, M., Chen, Y., Li, J., Nguyen, N., ... Dashwood, R. H. (2021). Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells.. Cancers (Basel). 13(6), 1438-1438.

Ulusan, A. M., Rajendran, P., Dashwood, W. M., Yavuz, O. F., Kapoor, S., Gustafson, T. A., ... Dashwood, R. H. (2021). Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).. Cancer Prev Res (Phila). 14(3), 325-336.

Johnson, G. S., Rajendran, P., & Dashwood, R. H. (2020). CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis.. Cancer Sci. 111(10), 3416-3425.

Okonkwo, A., Mitra, J., Johnson, G. S., Li, L. i., Dashwood, W. M., Hegde, M. L., ... Rajendran, P. (2018). Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.. Mol Nutr Food Res. 62(18), e1800228-1800228.

Johnson, G. S., Li, J., Beaver, L. M., Dashwood, W. M., Sun, D., Rajendran, P., ... Dashwood, R. H. (2017). A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.. Mol Nutr Food Res. 61(4), 1600769-1600769.

Kapoor, S., Gustafson, T., Zhang, M., Chen, Y., Li, J., Nguyen, N., ... Dashwood, R. (2021). Combined deacetylase and bromodomain inhibition downregulates ERCC2 and suppresses growth of metastatic colon cancer cells.. CANCER RESEARCH. 81(13),

Demirhan, Y. E., Rajendran, P., Dashwood, W., Kapoor, S., Ulusan, A., Tripathi, C., ... Dashwood, R. (2021). Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP. AMERICAN JOURNAL OF GASTROENTEROLOGY. 116, S138-S138.

Rajendran, P., Ulusan, A., Dashwood, W., Kapoor, S., Mohammed, A., Sei, S., ... Dashwood, R. H. (2020). Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention. Molecular and Cellular Biology / Genetics, Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. 80(16), 21-21.

Rajendran, P., Damiani, E., Wang, S., Dashwood, W., & Dashwood, R. H. (2020). Abstract 3477: Dietary polyphenols as epigenetic ‘reader' inhibitors. Molecular and Cellular Biology / Genetics, Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. 80(16), 3477-3477.

Ulusan, A., Rajendran, P., Dashwood, W., Mohammed, A., Sei, S., Brown, P. H., Vilar-Sanchez, E., & Dashwood, R. H. (2019). Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP. Cancer Research. 79(13_Supplement), 5074-5074.